Jump to content


Congrats to Margaret, Platinum Member with 1,000 posts and 10 Years of Forums Membership!


Photo

Efficacy And Safety Of Rituximab In Patients With Diffuse Scleroderma (SSc): An Up To 2 Years Follow Up Study.


  • Please log in to reply
No replies to this topic

#1 Joelf

Joelf

    Star Ruby Member

  • ISN Root Admin
  • PipPipPipPipPipPipPipPipPipPipPipPipPip
  • 4,616 posts
  • Location:West Sussex

Posted 14 September 2011 - 12:46 AM

Efficacy And Safety Of Rituximab In Patients With Diffuse Scleroderma (SSc): An Up To 2 Years Follow Up Study.

Results indicate that long term treatment with RTX may favorably affect lung function and skin fibrosis in patients with SSc. D. Daoussis. EULAR 2011 FRI0403. Ann rheumatologist Dis 2011;70(Suppl3):480. (Also see: Biologics)

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.

Jo Frowde
ISN Assistant Webmaster

SD World Webmaster
ISN Sclero Forums Manager
ISN News Manager

ISN Hotline Support Specialist
ISN Chat Host
International Scleroderma Network (ISN)